Cargando…

Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease

As individuals age, microglia, the resident immune cells of the central nervous system (CNS), become less effective at preserving brain circuits. Increases in microglial inflammatory activity are thought to contribute to age-related declines in cognitive functions and to transitions toward mild cogn...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKee, Chloe G., Hoffos, Madison, Vecchiarelli, Haley A., Tremblay, Marie-Ève
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034122/ https://www.ncbi.nlm.nih.gov/pubmed/36969855 http://dx.doi.org/10.3389/fphar.2023.1125982

Ejemplares similares

Psychological Stress as a Risk Factor for Accelerated Cellular Aging and Cognitive Decline: The Involvement of Microglia-Neuron Crosstalk
por: Carrier, Micaël, et al.
Publicado: (2021)

Editorial: Insights on neuroinflammatory response by microglia-targeted pharmacology
por: Raber, Jacob, et al.
Publicado: (2023)

Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic
por: Gonçalves de Andrade, Elisa, et al.
Publicado: (2021)

Traditional used Plants against Cognitive Decline and Alzheimer Disease
por: Eckert, Gunter Peter
Publicado: (2010)

Microglia Function in Alzheimer’s Disease
por: Solito, Egle, et al.
Publicado: (2012)

Enhancing axonal myelination in seniors: A review exploring the potential impact cannabis has on myelination in the aged brain
por: Murray, Colin J., et al.
Publicado: (2023)

Microbiota‐microglia connections in age‐related cognition decline
por: Zhou, Rui, et al.
Publicado: (2022)

TRPV1-Mediated Microglial Autophagy Attenuates Alzheimer’s Disease-Associated Pathology and Cognitive Decline
por: Wang, Chenfei, et al.
Publicado: (2022)

Sex Differences of Microglia and Synapses in the Hippocampal Dentate Gyrus of Adult Mouse Offspring Exposed to Maternal Immune Activation
por: Hui, Chin Wai, et al.
Publicado: (2020)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
por: Colomier, Esther, et al.
Publicado: (2021)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Advances in Alzheimer’s disease’s pharmacological treatment
por: Conti Filho, Carlos Elias, et al.
Publicado: (2023)

Microglia Susceptibility to Free Bilirubin Is Age-Dependent
por: Vaz, Ana Rita, et al.
Publicado: (2020)

All roads lead to heterogeneity: The complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer’s disease
por: St-Pierre, Marie-Kim, et al.
Publicado: (2022)

Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer’s Disease
por: Gottesman, Reena T., et al.
Publicado: (2019)

Mapping new pharmacological interventions for cognitive function in Alzheimer’s disease: a systematic review of randomized clinical trials
por: Xu Lou, Inmaculada, et al.
Publicado: (2023)

Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress
por: Bisht, Kanchan, et al.
Publicado: (2018)

Rescue of Noradrenergic System as a Novel Pharmacological Strategy in the Treatment of Chronic Pain: Focus on Microglia Activation
por: Caraci, Filippo, et al.
Publicado: (2019)

Microglia and Synapse: Interactions in Health and Neurodegeneration
por: Šišková, Zuzana, et al.
Publicado: (2013)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
por: Cuello, A. Claudio, et al.
Publicado: (2019)

Cognitive Declines Precede and Predict Functional Declines in Aging and Alzheimer’s Disease
por: Zahodne, Laura B., et al.
Publicado: (2013)

Levetiracetam attenuates diabetes-associated cognitive impairment and microglia polarization by suppressing neuroinflammation
por: Zhang, Yun-yun, et al.
Publicado: (2023)

Microglia as a Hub for Suicide Neuropathology: Future Investigation and Prevention Targets
por: Gonçalves de Andrade, Elisa, et al.
Publicado: (2022)

Targeting Multiple Mitochondrial Processes by a Metabolic Modulator Prevents Sarcopenia and Cognitive Decline in SAMP8 Mice
por: Brunetti, Dario, et al.
Publicado: (2020)

Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
por: Cassano, Tommaso, et al.
Publicado: (2019)

Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease
por: Shi, Zhikun, et al.
Publicado: (2022)

Ultrastructural characterization of dark microglia during aging in a mouse model of Alzheimer’s disease pathology and in human post-mortem brain samples
por: St-Pierre, Marie-Kim, et al.
Publicado: (2022)

Lipid Membranes as Key Targets for the Pharmacological Actions of Ginsenosides
por: Verstraeten, Sandrine L., et al.
Publicado: (2020)

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019)

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis
por: Wang, Jiaying, et al.
Publicado: (2019)

Dark microglia: Why are they dark?
por: Bisht, Kanchan, et al.
Publicado: (2016)

Cannabinoid CB(2) Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer’s Disease
por: Ruiz de Martín Esteban, Samuel, et al.
Publicado: (2022)

Pharmacological models in Alzheimer's disease research
por: Gilles, Christian, et al.
Publicado: (2000)

Integrated Network Pharmacology and Comprehensive Bioinformatics Identifying the Mechanisms and Molecular Targets of Yizhiqingxin Formula for Treatment of Comorbidity With Alzheimer’s Disease and Depression
por: Zhang, Tingting, et al.
Publicado: (2022)

Nutraceuticals in cognitive impairment and Alzheimer’s disease
por: Mecocci, P., et al.
Publicado: (2014)

Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development
por: Acheson, Dean T., et al.
Publicado: (2013)

Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer’s Disease: A Systematic Review
por: Theleritis, Christos G., et al.
Publicado: (2019)

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
por: Luo, Yunxia, et al.
Publicado: (2020)

Pharmacological Targeting of the Hepcidin/Ferroportin Axis
por: Sebastiani, Giada, et al.
Publicado: (2016)

Shedding Light on the Dark Side of the Microglia
por: St-Pierre, Marie-Kim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3to5m8ve7hrv9ptm0ekk0opdun